Andrej Trauner, Swiss TPH, wins the Swiss TB Award 2018 for his research on the mechanics of combination therapy against TB. (photo: Joachim Pelikan/Swiss TPH)
Tuberculosis still kills 1.7 million people annually and the rate of resistance against current treatments continues to increase. It is therefore key that we understand this infectious disease better and devise new treatments to control it. To mark World Tuberculosis Day on 24 March, the Swiss Foundation for Tuberculosis Research gave this year's Swiss TB Award to Andrej Trauner and Anna Rominski. Andrej Trauner, scientist at Swiss TPH, receives the award in recognition of his research on the mechanics of combination therapy against tubercle bacilli. Approximately 10 million people will be infected with tuberculosis (TB) in 2018 alone. In most cases the infection will be curable, however for many people the infection will mark the beginning of a long struggle with drug resistant TB. Why does combination therapy work as well as it does? Drug resistance in TB is as old as the efforts to treat the disease with antibiotics.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
